Post by Hologic, Inc.

Today we announced an important ruling from the Unified Patent Court in Germany, which found that Siemens infringed upon a critical Hologic mammography technology patent in Siemens’ latest mammography system. The court imposed a sweeping injunction, immediately prohibiting Siemens from making, offering, placing on the market, using or importing or storing for those purposes its MAMMOMAT B.brilliant systems across Germany, France and the Netherlands, as well as monetary damages and penalties for non-compliance. “This ruling is a decisive validation of the strength and originality of Hologic’s innovation — and, more importantly, of the standards we believe women deserve in breast cancer screening,” said Essex Mitchell, Chief Operating Officer at Hologic. Read more: https://ow.ly/Splp50Zcptg